Cannabidiol Modulates Neuroinflammatory and Estrogen-Related Pathways in a Sex-Specific Manner in a Chronic Stress Model of Depression by Uri Bright, Irit Akirav

Subjects: Get full text

Cannabidiol attenuates lipid metabolism and induces CB1 receptor-mediated ER stress associated apoptosis in ovarian cancer cells by Xuanhe Fu, Zhixiong Yu, Fang Fang, Weiping Zhou, Yuxin Bai, Zhongjia Jiang, Biao Yang, Ye Sun, Xing Tian, Guangyan Liu

Subjects: Get full text

Assessing Facial Thermal Nociceptive Response in Female Dogs After Elective Ovariohysterectomy Anesthetized with Isoflurane and Treated with Cannabidiol and Meloxicam Analgesia by Alejandro Casas-Alvarado, Patricia Mora-Medina, Ismael Hernández-Avalos, Julio Martínez-Burnes, Agatha Miranda-Cortes, Adriana Domínguez-Oliva, Daniel Mota-Rojas

“…The objective of this study was to assess the facial thermal nociceptive response produced by the use of cannabidiol (CBD) alone and in combination with meloxicam in female dogs undergoing elective ovariohysterectomy anesthetized with isoflurane. …”
Get full text

Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials by Alqassem Y. Hakami, Alqassem Y. Hakami, Fahad S. Alshehri

Subjects: Get full text

A high-fat meal significantly impacts the bioavailability and biphasic absorption of cannabidiol (CBD) from a CBD-rich extract in men and women by Bo Anne Daniëlla Frederique Saals, Tessa Helena De Bie, Eral Osmanoglou, Ties van de Laar, Adriaan Willem Tuin, Anne Claire Benedikte van Orten-Luiten, Renger Frederik Witkamp

“…Abstract Cannabidiol (CBD), a specialized metabolite (phytocannabinoid) abundant in Cannabis sativa, is attracting increasing attention for its alleged health-promoting properties. …”
Get full text

Feasibility pilot of a novel coaching intervention to optimize cannabis use for chronic pain management among Veterans by Kevin F. Boehnke, Gabrielle Bowyer, Jenna McAfee, Tristin Smith, Catherine Klida, Vivian Kurtz, Evangelos Litinas, Poonam Purohit, Anne Arewasikporn, Dana Horowitz, Laura Thomas, Jennifer Eckersley, Mia Railing, David A. Williams, Daniel J. Clauw, Kelley M. Kidwell, Amy S. B. Bohnert, Rachel S. Bergmans

Subjects: Get full text

CBD for pets: navigating quality assurance, safety standards, and marketing strategies by Hannah Rideout, Alasdair J. C. Cook, Anthony D. Whetton

Subjects: Get full text

Cost-Utility Analysis of Add-on Cannabidiol vs Usual Care Alone for the Treatment of Seizures in Patients With Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands by Jamshaed Siddiqui, Sally Bowditch

“…Since December 1, 2022, plant-derived highly purified cannabidiol (CBD) medicine (Epidyolex®; 100 mg/mL oral solution) has been reimbursed in the Netherlands for the adjunctive treatment of seizures associated with LGS or DS. …”
Get full text

First-year hemp farmers’ motives and resources to cultivate hemp by Blake Colclasure, Jason Caldwell, Tyler Granberry, Christine Rost, Bailey Gasseling

Subjects: Get full text

Antiseizure medication prescribing in people with Dravet syndrome: An analysis of real‐time administrative data by Kevin Y. Xu, Binx Yezhe Lin, M. Scott Perry, Fábio A. Nascimento

Subjects: Get full text

Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populations by R. Bortoletto, C. Comacchio, M. Garzitto, F. Piscitelli, M. Balestrieri, M. Colizzi

Subjects: Get full text

Refining management strategies for Lennox–Gastaut syndrome: Updated algorithms and practical approaches by Stéphane Auvin, Alexis Arzimanoglou, Mercè Falip, Pasquale Striano, J. Helen Cross

“…If seizure control remains suboptimal, subsequent adjunctive ASM treatment options include (alphabetically) cannabidiol, clobazam, felbamate, fenfluramine, and topiramate, although evidence for these is more limited. …”
Get full text

Cannabigerol and cannabichromene in Cannabis sativa L. by Zagožen Marjeta, Čerenak Andreja, Kreft Samo

“…In addition to delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), other phytocannabinoids, such as cannabigerol (CBG) and cannabichromene (CBC), also have beneficial effects on human health. …”
Get full text

Commercial Cannabinoid Oil-Induced Stevens-Johnson Syndrome by Han Y. Yin, Nicholas Hadjokas, Kanish Mirchia, Robert Swan, Samuel Alpert

“…To report an unusual presentation of commercial cannabidiol (CBD) oil-induced Stevens-Johnson Syndrome/toxic epidermal necrolysis (SJS-TEN). …”
Get full text

Cyclosporine and Herbal Supplement Interactions by D. Colombo, L. Lunardon, G. Bellia

“…Increased CyA concentration has been reported in patients with grapefruit juice, chamomile, or berberine, and with cannabidiol or resveratrol in animal studies. Effects of Echinacea and Serenoa repens on CyA levels have not been shown consistently, but concomitant use should be avoided. …”
Get full text

Phytocannabinoids: a new frontier in Alzheimer’s disease management by Jagadeesh S. Rao

“…Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are plant-derived compounds that have been well researched. …”
Get full text

Nanosilicon application changes the morphological attributes and essential oil compositions of hemp (Cannabis sativa L.) under water deficit stress by Ayyub Rezghiyan, Hassan Esmaeili, Mohsen Farzaneh

“…However, the highest content of cannabidiol in the essential oil was achieved in the severe water stress (40% FC) and treatment of 0.5 mM nanosilicon. …”
Get full text

Medical cannabis in the management of musculoskeletal pain: a systematic review of clinical trials by Przemysław Płatek, Laura Piejko

“…In this paper, we focus on two of the most extensively studied cannabinoids: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Recent scientific findings suggest that cannabinoids may be therapeutically beneficial for conditions such as neurodegenerative disorders, seizures, nausea and vomiting, insomnia, neuropathic pain, excessive muscle tension, fibromyalgia, osteoarthritis (OA), rheumatoid arthritis (RA), and chronic wounds. …”
Get full text

Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study by Saar Anis, Corinne Zalomek, Amos D. Korczyn, Alina Rosenberg, Nir Giladi, Tanya Gurevich

“…Δ9-Tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) content within MC product and monthly dose were titrated during the study. …”
Get full text

Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of Cannabis sativa female flower; in vitro, in vivo and in silico by Waqas Safir, Arif Malik, Arif Malik, Haleema Saadia, Ayesha Zahid, Jinyao Li

“…From the GC-MS analysis, the following bioactive compounds were found: cannabidiol (CBD), tetrahydrocannabinol (THC), and humulene. …”
Get full text